Discover key Q3 2025 earnings insights for Travere Therapeutics, including FILSPARI sales growth, FDA milestones, and outlook for rare kidney ...

Get key insights from Columbia Sportswear’s Q3 2025 earnings: tariff impacts, U.S. sales trends, global growth, and strategic plans.

Discover Ardelyx's Q3 2025 earnings highlights: record IBSRELA growth, raised revenue guidance, new pipeline expansion, and strong long-term outlook.

Horizon Kinetics spotlights six small-cap royalty and land firms with strategic exposure to resource scarcity and inflation.

Horizon Kinetics explores Altius Minerals’ royalty model amid rising potash demand, inflation trends, and commodity scarcity.

MakeMyTrip (MMYT) is a top buy with robust growth, expanding international reach, and resilient earnings. Read here for an ...

Discover Merit Medical Systems’ Q3 2025 earnings highlights—record margins, revenue growth, and strategic outlook under new CEO leadership.

Horizon Kinetics shows why gold royalty firms like Wheaton and Franco-Nevada outperform miners. Learn how to build ...

Discover Q3 2025 earnings insights for Entegris (ENTG): facility ramp progress, margin pressure, AI growth prospects, and cash flow improvement.

Horizon Kinetics explains why royalty trusts like Sabine outperform oil producers during inflation. Learn how to hedge energy ...

Discover Cloudflare's Q3 2025 earnings: accelerated revenue growth, rising enterprise traction, and AI innovation.

Discover OSI Systems' record Q1 2026 earnings, raised guidance, and growth in security and recurring revenues.